ReviewCancer pathogenesis and therapy2025
An overview of randomized phase III clinical trials of cancer nanomedicines.
Micael N Melo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ReviewCancer pathogenesis and therapy2025
Micael N Melo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.